Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation.

Eekman DA, ter Wee MM, Coupé VM, Erisek-Demirtas S, Kramer MH, Lems WF.

Osteoporos Int. 2014 Jan;25(1):195-204. doi: 10.1007/s00198-013-2505-4. Epub 2013 Sep 27.

PMID:
24072405
[PubMed - in process]
2.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

PMID:
23074491
[PubMed]
Free PMC Article
3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
4.

Direct medical costs attributable to peripheral fractures in Canadian post-menopausal women.

Bessette L, Jean S, Lapointe-Garant MP, Belzile EL, Davison KS, Ste-Marie LG, Brown JP.

Osteoporos Int. 2012 Jun;23(6):1757-68. doi: 10.1007/s00198-011-1785-9. Epub 2011 Sep 17.

PMID:
21927921
[PubMed - indexed for MEDLINE]
5.

Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET.

Pharmacoeconomics. 2010;28(5):395-409. doi: 10.2165/11531040-000000000-00000.

PMID:
20402541
[PubMed - indexed for MEDLINE]
6.

Health-economic comparison of three recommended drugs for the treatment of osteoporosis.

Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.

Int J Clin Pharmacol Res. 2004;24(1):1-10.

PMID:
15575171
[PubMed - indexed for MEDLINE]
7.

The economic burden of fracture patients with osteoporosis in western China.

Qu B, Ma Y, Yan M, Wu HH, Fan L, Liao DF, Pan XM, Hong Z.

Osteoporos Int. 2014 Jul;25(7):1853-60. doi: 10.1007/s00198-014-2699-0. Epub 2014 Apr 2.

PMID:
24691649
[PubMed - in process]
8.

Direct medical costs attributable to osteoporotic fractures.

Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Hammond CS, Melton LJ 3rd.

Osteoporos Int. 2002;13(4):323-30.

PMID:
12035765
[PubMed - indexed for MEDLINE]
9.

Osteoporotic fractures: a systematic review of U.S. healthcare costs and resource utilization.

Budhia S, Mikyas Y, Tang M, Badamgarav E.

Pharmacoeconomics. 2012 Feb 1;30(2):147-70. doi: 10.2165/11596880-000000000-00000. Review.

PMID:
22187933
[PubMed - indexed for MEDLINE]
10.

Cost-effectiveness of the treatment of traumatic thoracolumbar spine fractures: Nonsurgical or surgical therapy?

Siebenga J, Segers MJ, Leferink VJ, Elzinga MJ, Bakker FC, Duis HJ, Rommens PM, Patka P.

Indian J Orthop. 2007 Oct;41(4):332-6. doi: 10.4103/0019-5413.36997.

PMID:
21139788
[PubMed]
Free PMC Article
11.

Direct healthcare costs for 5 years post-fracture in Canada: a long-term population-based assessment.

Leslie WD, Lix LM, Finlayson GS, Metge CJ, Morin SN, Majumdar SR.

Osteoporos Int. 2013 May;24(5):1697-705. doi: 10.1007/s00198-012-2232-2. Epub 2013 Jan 23. Erratum in: Osteoporos Int. 2013 Nov;24(11):2901.

PMID:
23340947
[PubMed - indexed for MEDLINE]
12.

Costs and health effects of osteoporotic fractures.

Chrischilles E, Shireman T, Wallace R.

Bone. 1994 Jul-Aug;15(4):377-86.

PMID:
7917575
[PubMed - indexed for MEDLINE]
13.

[Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].

Picot MC, Neveu D, Kahane P, Crespel A, Gélisse P, Hirsch E, Derambure P, Dupont S, Landré E, Chassoux F, Valton L, Vignal JP, Marchal C, Rougier A, Lamy C, Semah F, Biraben A, Arzimanoglou A, Petit J, Thomas P, Dujols P, Ryvlin P.

Rev Neurol (Paris). 2004 Jun;160 Spec No 1:5S354-67. Review. French.

PMID:
15331984
[PubMed - indexed for MEDLINE]
14.

A health economic analysis of osteoporotic fractures: who carries the burden?

Hansen L, Mathiesen AS, Vestergaard P, Ehlers LH, Petersen KD.

Arch Osteoporos. 2013;8(1-2):126. doi: 10.1007/s11657-013-0126-3. Epub 2013 Feb 19.

PMID:
23420317
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.

Scotland G, Waugh N, Royle P, McNamee P, Henderson R, Hollick R.

Pharmacoeconomics. 2011 Nov;29(11):951-61. doi: 10.2165/11589310-000000000-00000. Review.

PMID:
21854080
[PubMed - indexed for MEDLINE]
16.

The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.

Stevenson M, Davis S, Lloyd-Jones M, Beverley C.

Health Technol Assess. 2007 Feb;11(4):1-134. Review.

PMID:
17280622
[PubMed - indexed for MEDLINE]
Free Article
17.

Costs and quality of life associated with osteoporosis-related fractures in Sweden.

Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Lunsjö K, Thorngren KG, Sernbo I, Rehnberg C, Jönsson B.

Osteoporos Int. 2006;17(5):637-50. Epub 2005 Nov 9.

PMID:
16283064
[PubMed - indexed for MEDLINE]
18.

Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.

Heimeshoff M, Hollmeyer H, Schreyögg J, Tiemann O, Staab D.

Pharmacoeconomics. 2012 Sep 1;30(9):763-77. doi: 10.2165/11588870-000000000-00000.

PMID:
22690685
[PubMed - indexed for MEDLINE]
19.

The societal burden of osteoporosis in Sweden.

Borgström F, Sobocki P, Ström O, Jönsson B.

Bone. 2007 Jun;40(6):1602-9. Epub 2007 Mar 7.

PMID:
17433804
[PubMed - indexed for MEDLINE]
20.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk